vs
Side-by-side financial comparison of ADMA BIOLOGICS, INC. (ADMA) and Target Hospitality Corp. (TH). Click either name above to swap in a different company.
ADMA BIOLOGICS, INC. is the larger business by last-quarter revenue ($139.2M vs $73.5M, roughly 1.9× Target Hospitality Corp.). ADMA BIOLOGICS, INC. runs the higher net margin — 35.5% vs -20.3%, a 55.8% gap on every dollar of revenue. On growth, Target Hospitality Corp. posted the faster year-over-year revenue change (22.0% vs 18.4%). Over the past eight quarters, ADMA BIOLOGICS, INC.'s revenue compounded faster (30.4% CAGR vs 0.7%).
ADMA Biologics Inc. is a biopharmaceutical enterprise focused on the research, development, manufacturing and commercialization of specialty plasma-derived immunoglobulin therapies. It primarily operates in the United States, catering to patients with primary immunodeficiency and other immune-related disorders, healthcare providers and medical institutions across its core immune health therapeutic segment.
Target Hospitality is a company that provides workforce lodging and other temporary, modular housing used for oil, gas and mining operations; large-scale events; and disaster relief. Target Hospitality is based in The Woodlands, Texas, and also has offices in Williston, North Dakota; Denver, Colorado; Calgary, Alberta.
ADMA vs TH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $139.2M | $73.5M |
| Net Profit | $49.4M | $-14.9M |
| Gross Margin | 63.8% | 9.6% |
| Operating Margin | 45.1% | -22.9% |
| Net Margin | 35.5% | -20.3% |
| Revenue YoY | 18.4% | 22.0% |
| Net Profit YoY | -55.9% | -219.1% |
| EPS (diluted) | $0.20 | $-0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $139.2M | $73.5M | ||
| Q3 25 | $134.2M | $91.6M | ||
| Q2 25 | $122.0M | $54.9M | ||
| Q1 25 | $114.8M | $54.9M | ||
| Q4 24 | $117.5M | $60.2M | ||
| Q3 24 | $119.8M | $65.8M | ||
| Q2 24 | $107.2M | $67.5M | ||
| Q1 24 | $81.9M | $72.4M |
| Q4 25 | $49.4M | $-14.9M | ||
| Q3 25 | $36.4M | $-795.0K | ||
| Q2 25 | $34.2M | $-14.9M | ||
| Q1 25 | $26.9M | $-6.5M | ||
| Q4 24 | $111.9M | $12.5M | ||
| Q3 24 | $35.9M | $20.0M | ||
| Q2 24 | $32.1M | $18.4M | ||
| Q1 24 | $17.8M | $20.4M |
| Q4 25 | 63.8% | 9.6% | ||
| Q3 25 | 56.3% | 19.6% | ||
| Q2 25 | 55.1% | -0.6% | ||
| Q1 25 | 53.2% | 32.7% | ||
| Q4 24 | 53.9% | 61.5% | ||
| Q3 24 | 49.8% | 68.7% | ||
| Q2 24 | 53.6% | 69.4% | ||
| Q1 24 | 47.8% | 67.8% |
| Q4 25 | 45.1% | -22.9% | ||
| Q3 25 | 38.0% | 0.1% | ||
| Q2 25 | 35.1% | -30.8% | ||
| Q1 25 | 30.4% | -2.0% | ||
| Q4 24 | 32.6% | 34.5% | ||
| Q3 24 | 33.1% | 42.5% | ||
| Q2 24 | 36.6% | 43.8% | ||
| Q1 24 | 26.7% | 42.0% |
| Q4 25 | 35.5% | -20.3% | ||
| Q3 25 | 27.1% | -0.9% | ||
| Q2 25 | 28.1% | -27.2% | ||
| Q1 25 | 23.4% | -11.8% | ||
| Q4 24 | 95.2% | 20.8% | ||
| Q3 24 | 30.0% | 30.4% | ||
| Q2 24 | 29.9% | 27.2% | ||
| Q1 24 | 21.7% | 28.2% |
| Q4 25 | $0.20 | $-0.14 | ||
| Q3 25 | $0.15 | $-0.01 | ||
| Q2 25 | $0.14 | $-0.15 | ||
| Q1 25 | $0.11 | $-0.07 | ||
| Q4 24 | $0.45 | $0.12 | ||
| Q3 24 | $0.15 | $0.20 | ||
| Q2 24 | $0.13 | $0.18 | ||
| Q1 24 | $0.08 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $87.6M | $8.3M |
| Total DebtLower is stronger | $72.1M | $1.7M |
| Stockholders' EquityBook value | $477.3M | $389.3M |
| Total Assets | $624.2M | $530.2M |
| Debt / EquityLower = less leverage | 0.15× | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $87.6M | $8.3M | ||
| Q3 25 | $61.4M | $30.4M | ||
| Q2 25 | $90.3M | $19.2M | ||
| Q1 25 | $71.6M | $34.5M | ||
| Q4 24 | $103.1M | $190.7M | ||
| Q3 24 | $86.7M | $177.7M | ||
| Q2 24 | $88.2M | $154.3M | ||
| Q1 24 | $45.3M | $124.3M |
| Q4 25 | $72.1M | $1.7M | ||
| Q3 25 | $72.4M | $2.0M | ||
| Q2 25 | — | $26.3M | ||
| Q1 25 | — | $42.9M | ||
| Q4 24 | $72.3M | $1.5M | ||
| Q3 24 | — | $994.0K | ||
| Q2 24 | — | $1.1M | ||
| Q1 24 | — | $179.9M |
| Q4 25 | $477.3M | $389.3M | ||
| Q3 25 | $431.2M | $402.4M | ||
| Q2 25 | $398.3M | $401.3M | ||
| Q1 25 | $373.4M | $415.3M | ||
| Q4 24 | $349.0M | $421.1M | ||
| Q3 24 | $231.9M | $417.6M | ||
| Q2 24 | $188.3M | $397.2M | ||
| Q1 24 | $153.7M | $375.5M |
| Q4 25 | $624.2M | $530.2M | ||
| Q3 25 | $568.7M | $541.2M | ||
| Q2 25 | $558.4M | $533.7M | ||
| Q1 25 | $510.6M | $562.5M | ||
| Q4 24 | $488.7M | $725.8M | ||
| Q3 24 | $390.6M | $709.8M | ||
| Q2 24 | $376.4M | $697.0M | ||
| Q1 24 | $350.9M | $687.2M |
| Q4 25 | 0.15× | 0.00× | ||
| Q3 25 | 0.17× | 0.01× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.10× | ||
| Q4 24 | 0.21× | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.48× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $35.6M | $5.7M |
| Free Cash FlowOCF − Capex | $34.6M | — |
| FCF MarginFCF / Revenue | 24.8% | — |
| Capex IntensityCapex / Revenue | 0.8% | — |
| Cash ConversionOCF / Net Profit | 0.72× | — |
| TTM Free Cash FlowTrailing 4 quarters | $27.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $35.6M | $5.7M | ||
| Q3 25 | $13.3M | $53.4M | ||
| Q2 25 | $21.1M | $11.1M | ||
| Q1 25 | $-19.7M | $3.9M | ||
| Q4 24 | $50.2M | $30.6M | ||
| Q3 24 | $25.0M | $31.4M | ||
| Q2 24 | $45.6M | $39.1M | ||
| Q1 24 | $-2.2M | $50.6M |
| Q4 25 | $34.6M | — | ||
| Q3 25 | $-1.1M | — | ||
| Q2 25 | $18.7M | — | ||
| Q1 25 | $-24.4M | $-11.6M | ||
| Q4 24 | $47.5M | — | ||
| Q3 24 | $24.0M | — | ||
| Q2 24 | $43.6M | — | ||
| Q1 24 | $-4.6M | — |
| Q4 25 | 24.8% | — | ||
| Q3 25 | -0.8% | — | ||
| Q2 25 | 15.3% | — | ||
| Q1 25 | -21.2% | -21.1% | ||
| Q4 24 | 40.4% | — | ||
| Q3 24 | 20.0% | — | ||
| Q2 24 | 40.7% | — | ||
| Q1 24 | -5.6% | — |
| Q4 25 | 0.8% | — | ||
| Q3 25 | 10.7% | — | ||
| Q2 25 | 2.0% | — | ||
| Q1 25 | 4.1% | 28.2% | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | 2.9% | — |
| Q4 25 | 0.72× | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.62× | — | ||
| Q1 25 | -0.73× | — | ||
| Q4 24 | 0.45× | 2.44× | ||
| Q3 24 | 0.70× | 1.57× | ||
| Q2 24 | 1.42× | 2.13× | ||
| Q1 24 | -0.12× | 2.48× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADMA
| ADMA Bio Manufacturing Segment | $123.1M | 88% |
| Other | $16.0M | 12% |
TH
| Services | $40.9M | 56% |
| Hospitality And Facilities Services South | $32.6M | 44% |
